NAS
INDV icon

Nykredit A/S’s Indivior Pharmaceuticals INDV Stock Holding History

Nykredit A/S’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
+7,509
New +$272K ﹤0.01% 851

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nykredit A/S's INDV Position: Q2 2026 in Review

Nykredit A/S opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 7,509 shares worth $308K. The stake represents ﹤0.01% of the portfolio and ranks #851 among its holdings.

248 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Nykredit A/S held 7,509 shares of Indivior Pharmaceuticals worth $308K as of Q2 2026.
  • Indivior Pharmaceuticals was a new Nykredit A/S position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #851 holding.
  • 248 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.